/PRNewswire/ Avista Capital Partners ("Avista"), a leading New York-based private equity firm focused exclusively on healthcare, today announced that Don.
Form S-3 RVL Pharmaceuticals plc streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Avista s co-manager and co-CEO Dean to transition to chairman pehub.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pehub.com Daily Mail and Mail on Sunday newspapers.
Avista Capital Closes Fund V at $1 2B themiddlemarket.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themiddlemarket.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
NEW YORK, March 2, 2021 /PRNewswire/ Avista Capital Partners ( Avista or the Firm ), a leading New York-based healthcare private equity firm, today announced the final closing of Avista Capital Partners V, L.P. and Avista Capital Partners (Offshore) V, L.P. (collectively, Fund V or the Fund ). Fund V was over-subscribed, hit its hard-cap and substantially exceeded its target of $775 million, closing with committed capital of $1.2 billion.
Fund V is comprised of a diversified set of investors, including leading public pension funds, university endowments and foundations, family offices, insurance companies and asset managers across North America, Europe, Asia and the Middle East. Avista received widespread support from its Fund IV investors and is also pleased to welcome a host of new and distinguished investors, including Capital Constellation, with whom Avista formed a strategic partnership during 2020.